TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Net Income

Annual figures by fiscal year, from SEC filings.

2008: -$79.13M2009: -$67.83M2010: -$104.47M2011: -$221.76M2012: $750.27M2013: $413.74M2014: $338.13M2015: $636.06M2016: $895.50M2017: $1.20B2018: $2.44B2019: $2.12B2020: $3.51B2021: $8.08B2022: $4.34B2023: $3.95B2024: $4.41B2025: $4.50B$4.50B
2008Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$4.50B+2.1%
2024$4.41B+11.6%
2023$3.95B-8.9%
2022$4.34B-46.3%
2021$8.08B+129.9%
2020$3.51B+66.0%
2019$2.12B-13.4%
2018$2.44B+104.0%
2017$1.20B+33.8%
2016$895.50M+40.8%
2015$636.06M+88.1%
2014$338.13M-18.3%
2013$413.74M-44.9%
2012$750.27M+438.3%
2011-$221.76M-112.3%
2010-$104.47M-54.0%
2009-$67.83M+14.3%
2008-$79.13M—